"Market Access" describes activities and processes that pharmaceutical and biotech companies underta...
Read morePrescription drug prices in the US rank among the highest in the world and the US spent $1220 on ph...
Read moreThe Westminster Health Forum organise senior level conferences on public policy relating to health a...
Read moreWith the UKs withdrawal from the European Union, NICE’s relationship with EMA and indeed, the para...
Read moreNHS England is developing a new Commercial Framework, outlining potential opportunities for commerci...
Read moreMaximising the cost-saving potential of biosimilars remains a topic of much interest to payers and p...
Read moreDiscussing the benefits of seeking early scientific advice and what companies need to take into cons...
Read moreWhat are the pro’s and cons of seeking NICE approval using the Medical Technologies Evaluation Pro...
Read moreThis study investigates costs of gene/acute therapies versus chronic treatments for rare diseases, o...
Read moreHow to create, facilitate, and promote sustainable Health Technology Assessment (HTA) cooperation in...
Read more